KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/09/2026 13:14
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization219,471 mln
Float86.92 mln
Earnings Date07/30/2025
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-2.34
Borderline
Relative Strength
11
/ 100
Significantly lagging
Debt / Equity
0.96
Moderate leverage
Pre-Tax Margin
0%
Break-even
ROE
-3.85
Negative
Business Description
Founded in 1952 and based in Seoul, Yungjin Pharm is a South Korean subsidiary of KT&G Corporation that develops and sells a broad range of medicines and health products at home and abroad. Its portfolio covers treatments for heart conditions, respiratory issues, infections, mental health, and digestive problems, among others, as well as nutritional supplements, vitamins, minerals, and active pharmaceutical ingredients.
